Ознакомительная версия. Доступно 30 страниц из 146
38. Kaufmann, D. E., D. G. Kavanagh, F. Pereyra, J. J. Zaunders, E. W. Mackey, T. Miura, S. Palmer, et al. “Upregulation of CTLA-4 by HIV-Specific CD4+ T Cells Correlates with Disease Progression and Defines a Reversible Immune Dysfunction.” Nature Immunology 8 (2007): 1246–54.
39. “Role of IL-10 in HIV Patients.” B. Walker Laboratory and A. McMichael Laboratory, unpublished results, personal communications 2007.
40. Andrabi, R., J. N. Bhiman, and D. R. Burton. “Strategies for a Multi-Stage Neutralizing Antibody-Based HIV Vaccine.” Current Opinion in Immunology 53 (2018): 143–51.
41. Burton, D. R., and L. Hangartner. “Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.” Annual Review of Immunology 34 (2016): 635–59.
42. Walker, L. M., and D. R. Burton. “Rational Antibody-Based HIV-1 Vaccine Design: Current Approaches and Future Directions.” Current Opinion in Immunology 22 (2010): 358–66.
43. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. “Virus-Specific CD8+ Cytotoxic T-Lymphocyte Activity Associated with Control of Viremia in Primary Human Immunodeficiency Virus Type 1 Infection.” Journal of Virology 68 (1994): 6103–10.
44. Walker, B. D., S. Chakrabati, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. “HIV Specific Cytotoxic T Lymphocytes in Seropositive Individuals.” Nature 328 (1987): 345–48.
45. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, and B. H. Hahn. “Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection.” Science 373 (1995): 117–22.
46. Fauci, A. “AIDS: Newer Concepts in the Immunopathogenic Mechanism of Human Immunodeficiency Virus Disease.” Proceedings of the Association of American Physicians 107 (1995): 1–7.
47. Chun, T. W., J. S. Justement, P. Pandya, C. W. Hallahan, M. McLaughlin, S. Liu, L. A. Ehler, C. Kovacs, and A. S. Fauci. “Relationship Between the Size of the Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir in Peripheral Blood CD4+ T Cells and CD4+:CD8+ T Cell Ratios in Aviremic HIV-1-Infected Individuals Receiving Long-Term Highly Active Antiretroviral Therapy.” Journal of Infectious Diseases 185 (2002): 1672–76.
48. Chun, T. W., D. C. Nickle, J. S. Justement, J. H. Meyers, G. Roby, C. W. Hallahan, S. Kottilil, et al. “Persistence of HIV in Gut-Associated Lymphoid Tissue Despite Long-Term Antiretroviral Therapy.” Journal of Infectious Diseases 197 (2008): 714–20.
49. Guadalupe, M., E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar. “Severe CD4+ T– Cell Depletion in Gut Lymphoid Tissue During Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration Following Highly Active Antiretroviral Therapy.” Journal of Virology 77 (2003): 11708–17.
50. Wiley, C., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. “Cellular Localization of Human Immunodeficiency Virus Infection Within the Brains of Acquired Immunodeficiency Syndrome Patients.” Proceedings of the National Academy of Sciences USA 83 (1986): 7089–93.
51. Moses, A. V., and J. A. Nelson. “HIV Infection of Human Brain Capillary Endothelial Cells – Implications for AIDS Dementia.” Advances in Neuroimmunology 4 (1994): 239–47.
52. Pierson, T., J. McArthur, and R. F. Siliciano. “Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy.” Annual Review of Immunology 18 (2000): 665–708.
53. Le Gall, S., L. Erdtmann, S. Benichou, C. Berlioz-Torrent, L. Liu, R. Benarous, J. M. Heard, and O. Schwartz. “Nef Interacts with the Mu Subunit of Clathrin Adaptor Complexes and Reveals a Cryptic Sorting Signal in MHC 1 Molecules.” Immunity 8 (1998): 483–95.
54. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo,O. Schwartz, and P. Benaroch. “HIV-1 Nef Impairs MHC Class II Antigen Presentation and Surface Expression.” Proceedings of the National Academy of Sciences USA 98 (2001): 12144–49.
55. Yang, O. O., P. T. Nguyen, S. A. Kalams, T. Dorfman, H. G. Göttlinger, S. Stewart, I. S. Chen, S. Threlkeld, and B. D. Walker. “Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes.” Journal of Virology 76 (2002): 1626–31.
56. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. “The Antigenic Structure of the HIV gp120 Envelope Glycoprotein.” Nature 393 (1998): 705–11.
57. Kwong, P. D., R. Wyatt, S. Majeed, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. “Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates.” Structure 8 (2000): 1329–39.
58. Haase, A. T., E. F. Retzel, and K. A. Staskus. “Amplification and Detection of Lentiviral DNA Inside Cells.” Proceedings of the National Academy of Sciences USA 87 (1990): 4971–75.
59. Harper, M. E., L. M. Marselle, R. C. Gallo, and F. Wong-Staal. “Detection of Lymphocytes Expressing Human T-Lymphocyte Virus Type III in Lymph Nodes and Peripheral Blood from Infected Individuals by In Situ Hybridization.” Proceedings of the National Academy of Sciences USA 83 (1986): 772–76.
60. Chun, T. W., and A. S. Fauci. “Latent Reservoirs of HIV: Obstacles to the Eradication of Virus.” Proceedings of the National Academy of Sciences USA 96 (1999): 10958–61.
61. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, et al. “Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy.” Science 278 (1997): 1295–1300.
62. Yarchoan, R. “HIV and KSHV-Related Cancers: Diseases at the Crossroads of Virology, Immunology, and Cell Biology.” Microbe 10 (2015): 157–62.
63. McFadyean, J., and F. Hobday. “Note on the Experimental Transmission of Warts in the Dog.” Journal of Comparative Pathology and Therapeutics 11 (1898): 341–44.
64. Zur Hausen, H. “Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas.” Current Topics in Microbiology and Immunology 78 (1977): 1–30.
65. Lowy, D. R., and J. T. Schiller. “Prophylactic Human Papillomavirus Vaccines.” Journal of Clinical Investigation 116 (2006): 1167–73.
66. Frazer, I. H. “Prevention of Cervical Cancer Through Papillomavirus Vaccination.” Nature Reviews Immunology 4 (2004): 46–54.
67. Loeffler, F., and P. Frosch. “Berichte der Kommission zur Erforschung der Maul und Klauenseuche bei dem Institut Fur Infektionskrankheiten in Berlin.” Zentralblatt für Bakteriologie Parasitenkunde und Infektionskrankheiten I. 23 (1898): 371.
Ознакомительная версия. Доступно 30 страниц из 146
